Edwards Lifesciences Hemodynamic Monitoring Edwards Lifesciences Hemodynamic Monitoring

Flotrac System

The clarity to consistently maintain
patients in the optimal volume range

Flotrac System

The clarity to consistently maintain
patients in the optimal volume range

The FloTrac system automatically updates advanced parameters every 20 seconds, reflecting rapid physical changes in moderate to high-risk surgery more accurately. Advanced hemodynamic parameters provided by the FloTrac sensor offer you continuous insight to more accurately determine your patient’s fluid status. The minimally-invasive FloTrac sensor connects to any existing arterial catheter.

Flotrac System

In just a decade, the FloTrac sensor has been chosen by clinicians more than any other volume management solution to manage over 2.5 million patients worldwide.*†

FloTrac and EV1000
FloTrac History
FloTrac Parameters
EV1000 Clinical Output
FloTrac and EV1000

FloTrac History

FloTrac Parameters

EV1000 Clinical Output

The FloTrac system algorithm has evolved based on a broad and expanding patient database that allows ongoing system performance improvements. In this latest evolution (v.4.0), Edwards continues to expand the database to include a more diverse surgical patient population in order to continuously inform and evolve the algorithm. Specifically, more of the following high-risk surgical patients were added to the database including, but not limited to:

  • GI
  • Esophogael
  • Pancreaticoduodenectomy (Whipple)
  • Kidney Transplant
  • Nephrectomy
  • Hip Replacement Esophagectomy

FloTrac System Algorithm

FloTrac sensor

ModelDescriptionLengthUnit of Measure
MHD8 FloTrac sensor 84 in / 213 cm EA
MHD85 FloTrac sensor 84 in / 213 cm 5 EA
MHD6 FloTrac sensor 60 in / 152 cm EA
MHD65 FloTrac sensor 60 in / 152 cm 5 EA
MHD6AZ FloTrac sensor with VAMP adult system 60 in / 152 cm EA
MHD6AZ5 FloTrac sensor with VAMP adult system 60 in / 152 cm 5 EA

EV1000 clinical platform

ModelDescription
EVFTC1 FloTrac Short
EVFTCL FloTrac Long
EVEC1 Ethernet Short
EVECL Ethernet Long
EVVVTC1 VolumeView Cable
EVMB1 Monitor Bracket
EVBB1 Databox Bracket
EVPB1 Power Adapter Bracket
EVS1 Table Stand
EVPSB220 Power Adapter, 220V (Class I)
EVPSB220L Power Adapter, 220V Long (Class I)
EVDTH4 Transducer Holder
EV1000A EV1000 Platform
EVRS Rollstand

*Data on file
The FloTrac system is comprised of the FloTrac sensor and the Vigileo monitor or the EV1000 clinical platform.

Clinical Application

Advanced hemodynamic parameters, when implemented within a PGDT protocol, are demonstrated to reduce post-surgical complications in moderate to high-risk surgery patients. 19 The FloTrac system provides advanced hemodynamic paratmeters that can be used in PGDT to control variability in volume administration and help you maintain your patient in the optimal volume range.

Frank-Starling Curve and Bellamy Curve

  • Stroke Volume Optimization (SV) 4–12

Stroke volume measurement with the FloTrac sensor enables an individualized approach for administering fluid until SV reaches a plateau on the Frank-Starling curve, to prevent hypovolemia and excessive fluid administration.

  • Stroke Volume Variation Optimization (SVV) 13

For control-ventilated patients, SVV has proved to be a highly sensitive and specific indicator for pre-load responsiveness, serving as an accurate marker of patient status on the Frank-Starling curve.

  • Oxygen Delivery Optimization (DO 2 with CCO) 14

Continuous cardiac output (CCO) measured by the FloTrac system can be used (in combination with SaO 2 and hemoglobin) to monitor and optimize DO 2 with fluid (including red blood cells) and inotropic agents.

30+ randomized controlled trials and 14+ metaanalyses have demonstrated clinical benefits of hemodynamic optimization over traditional volume management. 15-18

Advanced hemodynamic parameters, when implemented within a PGDT protocol, are demonstrated to reduce postsurgical complications in moderate to high-risk surgery patients. 19 The FloTrac system provides advanced hemodynamic parameters that can be used in PGDT to control variability in volume administration and help you maintain your patient in the optimal volume range.

Hemodynamic Education

Edwards Critical Care Education

Edwards has been providing science-based education since 1972.  We offer a full range of on-line, in-print and on-site programs that are available to your clinicians or staff.

Following are relevant educational tools:

PRODUCT IMPLEMENTATION

An integrated hemodynamic monitoring system

The FloTrac sensor integrates with the Edwards EV1000 clinical platform to show patient status at a glance, for visual clinical support and increased clarity in volume administration during moderate to high-risk surgical procedures.

The EV1000 clinical platform now offers the next perspective on guiding volume administration when used with the FloTrac system. The latest visual clinical support screens available on the EV1000 clinical platform enable you to maintain your patients in the optimal volume range and reduce volume administration variability. Time In Target facilitates Perioperative Goal-Directed Therapy (PGDT) compliance, helping the user to track and manage key parameters, and create and monitor customized protocols.

Click here for complete software requirements and to download your PGDT analytics software.

This latest software update includes expanded monitoring, specifically:

  • Addition of SVR parameter by adding a CVP updates
  • Addition of blood pressures and pulse rate at key parameters
  • MAP, SYS and DIA as primary parameters
  • Ability to view BP waveform

To update your existing EV1000 clinical platform, contact Edwards Lifesciences today.

Contact Edwards Lifesciences

EV1000 Clinical Platform

Product and Setup Guides


Related Products

Edwards’ range of hemodynamic monitoring solutions offers continuous dynamic and flow-based parameters that may be used in PGDT to consistently maintain your moderate to high-risk surgery patients in the optimal volume range.


Contact a Sales Rep

  1. Marik & Cavallazzi. Does central venous pressure predict fluid responsiveness? An updated meta-analysis and a plea for some common sense. Crit Care Med 2013
  2. Le Manach et al. Can changes in arterial pressure be used to detect changes in cardiac output during volume expansion in the perioperative period? Anesthesiology 2013
  3. Bennett D. Arterial Pressure: A Personal View. Functional Hemodynamic Monitoring. Berlin: Springer-Verlag, 2005. ISBN: 3-540-22349-5
  4. Cecconi M, Fasano N, Langiano N, et al. Goal directed haemodynamic therapy during elective total hip arthroplasty under regional anaesthesia. Crit Care. 2011;15:R132
  5. Sinclair S, James S, Singer M. Intraoperative intravascular volume optimization and length of hospital stay after repair of proximal femoral fracture: randomised controlled trial. AMJ. 1997;315:909–912.
  6. Gan T, Soppitt A, Maroof M, et al. Goal-directed intraoperative fluid administration reduces length of hospital stay after major surgery. Anesthesiology. 2002;97(4):820–826.
  7. Venn R, Richardson P, Poloniecki J, Grounds M, Newman P. Randomized controlled trial to investigate influence of the fluid challenge on duration of hospital stay and perioperative morbidity in patients with hip fractures. Br J Anaesth. 2002;88(1):65–71.
  8. Conway D, Mayall R, Abdul-Latif M, Gilligan S, Tackaberry C. Randomised controlled trial investigating the influence of intravenous fluid titration using oesophageal Doppler monitoring during bowel surgery. Anaesthesia. 2002;57(9):845–849.
  9. McKendry M, McGloin H, Saberi D, Caudwell L, Brady A, Singer M. Randomised controlled trial assessing the impact of a nurse delivered, flow monitored protocol for optimisation of circulatory status after cardiac surgery. BMJ. 2004;329:358.
  10. Wakeling H, McFall M, Jenkins C, Woods W, Barclay G, Fleming S. Intraoperative oesophageal Doppler-guided fluid management shortens postoperative hospital stay after major bowel surgery. Br J Anaesth. 2005;95(5):634–642
  11. Noblett S, Snowden C, Shenton B, Horgan A. Randomized clinical trial assessing the effect of Doppler-optimized fluid management on outcome after elective colorectal resection. BJS. 2006;93(9):1069–1076.
  12. ChytraI, Pradl R, Bosman R, Pelnar P, Kasal E, Zidkova A. Esophageal Doppler-guided fluid management decreases blood lactate levels in multiple-trauma patients: a randomized controlled trial. Crit Care. 2007;11:R24.
  13. Benes J, ChytraI, Altmann P, et al. Intraoperative fluid optimization using stroke volume variation in high risk surgical patients: results of prospective randomized study. Crit Care. 2010;14:1-15.
  14. Donati A, Loggi S, Preiser JC, Orsetti G, Munch C, Gabbanelli V, Pelaia P, Pietropaoli P. Goal-directed intraoperative therapy reduces morbidity and length of hospital stay in high-risk surgical patients. Chest. 2007;132:1817–1824.
  15. Grocott et al. Perioperative increase in global blood flow to explicit defined goals and outcomes after surgery: a Cochrane systematic review. Br J Anaesth 2013
  16. Giglio MT, Marucci M, Testini M, Brienza N. Goal-directed haemodynamic therapy and gastrointestinal complications in major surgery: a meta-analysis of randomized controlled trials. Br J Anaesth 2009; 103: 637–46
  17. Dalfino L, Giglio MT, Puntillo F, Marucci M, Brienza N. Haemodynamic goal-directed therapy and postoperative infections: earlier is better. A systematic review and meta-analysis. Crit Care 2011; 15: R154
  18. Corcoran T et al. Perioperative Fluid Management Strategies in Major Surgery: A Stratified Meta-Analysis. Anesthesia – Analgesia 2012
  19. Hamilton MA, Cecconi M, Rhodes A. A systematic review and meta-analysis on the use of preemptive hemodynamic intervention to improve postoperative outcomes in moderate and high risk surgical patients. Anesthesia – Analgesia 2011; 112: 1392–402.
  20. CL Gurudatt. Perioperative fluid therapy: How much is not too much? Indian J Anaesth. 2012 Jul-Aug; 56(4): 323–325

For Professional Use

For Professional Use

See instructions for use for full prescribing information, including indications, contraindications, warnings, precautions and adverse event.

Edwards Lifesciences devices placed on the European market meeting the essential requirements referred to in Article 3 of the Medical Device Directive 93/42/EEC bear the CE marking of conformity.

Please update your browser

Please update to a current version of your preferred browser, this site will perform effectively on the following:

Unable to update your browser?

If you are on a computer, that is maintained by an admin and you cannot install a new browser, ask your admin about it. If you can't change your browser because of compatibility issues, think about installing a second browser for browsing and keep this old one for compatibility